Cargando…

FRI530 Immune-Modulation By Rapamycin, Or Mycophenolic Acid, Of Th1 And Th2 Chemokines Secretion In Retro-orbital Cells Of Patients With Graves’ Ophthalmopathy

Disclosure: G. Elia: None. F. Ragusa: None. S. Paparo: None. V. Mazzi: None. A. Patrizio: None. P. Fallahi: None. A. Antonelli: None. S. Ferrari: None. Objectives: Cytokines and chemokines contribute to the inflammation of Graves’ ophthalmopathy (GO). Indeed cytokines stimulate the T helper (Th)1 an...

Descripción completa

Detalles Bibliográficos
Autores principales: Elia, Giusy, Ragusa, Francesca, Rosaria Paparo, Sabrina, Mazzi, Valeria, Patrizio, Armando, Fallahi, Poupak, Antonelli, Alessandro, Martina Ferrari, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553459/
http://dx.doi.org/10.1210/jendso/bvad114.1875
_version_ 1785116175503458304
author Elia, Giusy
Ragusa, Francesca
Rosaria Paparo, Sabrina
Mazzi, Valeria
Patrizio, Armando
Fallahi, Poupak
Antonelli, Alessandro
Martina Ferrari, Silvia
author_facet Elia, Giusy
Ragusa, Francesca
Rosaria Paparo, Sabrina
Mazzi, Valeria
Patrizio, Armando
Fallahi, Poupak
Antonelli, Alessandro
Martina Ferrari, Silvia
author_sort Elia, Giusy
collection PubMed
description Disclosure: G. Elia: None. F. Ragusa: None. S. Paparo: None. V. Mazzi: None. A. Patrizio: None. P. Fallahi: None. A. Antonelli: None. S. Ferrari: None. Objectives: Cytokines and chemokines contribute to the inflammation of Graves’ ophthalmopathy (GO). Indeed cytokines stimulate the T helper (Th)1 and Th2 chemokines release from orbital cells (fibroblasts, preadipocytes and myocytes).We aim to investigate the effects of rapamycin or mycophenolic acid on the secretion of these chemokines in GO orbital cells. Methods: We obtained primary cultures of fibroblasts, preadipocytes and myoblasts from the orbits of GO patients, and we tested increasing concentrations of rapamycin and/or mycophenolic acid evaluating the secretion of the prototype Th1 [chemokine (C-X-C motif) ligand 10 (CXCL10)] and Th2 [chemokine (C-C motif) ligand 2 (CCL2)] chemokines. Results: We observed that CXCL10 secretion in the retro-orbital cells of GO was undetectable in the supernatants, whereas interferon (IFN)-gamma induce its release in a dose-dependently manner. No effect was observed under the tumor necrosis factor (TNF)-alpha stimuli, while the combination of both cytokines had a significant synergistic effect on CXCL10 secretion. As regards the effect on the CCL2 secretion, it was released in low amounts in basal condition; TNF-alpha dose-dependently induced its release, whereas IFN-gamma alone had no effect. The combination of TNF-alpha plus IFN-gamma had a significant synergistic effect on CCL2 secretion. By adding mycophenolic acid, or rapamycin, (in a pharmacological range) at the time of IFN-gamma and TNF-alpha stimulation, we observed a dose-dependently inhibitory effect on the chemokines release in the retro-orbital cells of GO. Furthermore, the combination of mycophenolic acid with rapamycin, have a synergistic inhibitory effect on the release of chemokines. Conclusion: Our data showed an immune-modulating effect of mycophenolic acid or rapamycin on the Th1 and Th2 chemokines secretion, in GO orbital cells. These findings suggest the therapeutic role of these drugs that could obtained, at least in part, through this mechanism. Presentation: Friday, June 16, 2023
format Online
Article
Text
id pubmed-10553459
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-105534592023-10-06 FRI530 Immune-Modulation By Rapamycin, Or Mycophenolic Acid, Of Th1 And Th2 Chemokines Secretion In Retro-orbital Cells Of Patients With Graves’ Ophthalmopathy Elia, Giusy Ragusa, Francesca Rosaria Paparo, Sabrina Mazzi, Valeria Patrizio, Armando Fallahi, Poupak Antonelli, Alessandro Martina Ferrari, Silvia J Endocr Soc Thyroid Disclosure: G. Elia: None. F. Ragusa: None. S. Paparo: None. V. Mazzi: None. A. Patrizio: None. P. Fallahi: None. A. Antonelli: None. S. Ferrari: None. Objectives: Cytokines and chemokines contribute to the inflammation of Graves’ ophthalmopathy (GO). Indeed cytokines stimulate the T helper (Th)1 and Th2 chemokines release from orbital cells (fibroblasts, preadipocytes and myocytes).We aim to investigate the effects of rapamycin or mycophenolic acid on the secretion of these chemokines in GO orbital cells. Methods: We obtained primary cultures of fibroblasts, preadipocytes and myoblasts from the orbits of GO patients, and we tested increasing concentrations of rapamycin and/or mycophenolic acid evaluating the secretion of the prototype Th1 [chemokine (C-X-C motif) ligand 10 (CXCL10)] and Th2 [chemokine (C-C motif) ligand 2 (CCL2)] chemokines. Results: We observed that CXCL10 secretion in the retro-orbital cells of GO was undetectable in the supernatants, whereas interferon (IFN)-gamma induce its release in a dose-dependently manner. No effect was observed under the tumor necrosis factor (TNF)-alpha stimuli, while the combination of both cytokines had a significant synergistic effect on CXCL10 secretion. As regards the effect on the CCL2 secretion, it was released in low amounts in basal condition; TNF-alpha dose-dependently induced its release, whereas IFN-gamma alone had no effect. The combination of TNF-alpha plus IFN-gamma had a significant synergistic effect on CCL2 secretion. By adding mycophenolic acid, or rapamycin, (in a pharmacological range) at the time of IFN-gamma and TNF-alpha stimulation, we observed a dose-dependently inhibitory effect on the chemokines release in the retro-orbital cells of GO. Furthermore, the combination of mycophenolic acid with rapamycin, have a synergistic inhibitory effect on the release of chemokines. Conclusion: Our data showed an immune-modulating effect of mycophenolic acid or rapamycin on the Th1 and Th2 chemokines secretion, in GO orbital cells. These findings suggest the therapeutic role of these drugs that could obtained, at least in part, through this mechanism. Presentation: Friday, June 16, 2023 Oxford University Press 2023-10-05 /pmc/articles/PMC10553459/ http://dx.doi.org/10.1210/jendso/bvad114.1875 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Thyroid
Elia, Giusy
Ragusa, Francesca
Rosaria Paparo, Sabrina
Mazzi, Valeria
Patrizio, Armando
Fallahi, Poupak
Antonelli, Alessandro
Martina Ferrari, Silvia
FRI530 Immune-Modulation By Rapamycin, Or Mycophenolic Acid, Of Th1 And Th2 Chemokines Secretion In Retro-orbital Cells Of Patients With Graves’ Ophthalmopathy
title FRI530 Immune-Modulation By Rapamycin, Or Mycophenolic Acid, Of Th1 And Th2 Chemokines Secretion In Retro-orbital Cells Of Patients With Graves’ Ophthalmopathy
title_full FRI530 Immune-Modulation By Rapamycin, Or Mycophenolic Acid, Of Th1 And Th2 Chemokines Secretion In Retro-orbital Cells Of Patients With Graves’ Ophthalmopathy
title_fullStr FRI530 Immune-Modulation By Rapamycin, Or Mycophenolic Acid, Of Th1 And Th2 Chemokines Secretion In Retro-orbital Cells Of Patients With Graves’ Ophthalmopathy
title_full_unstemmed FRI530 Immune-Modulation By Rapamycin, Or Mycophenolic Acid, Of Th1 And Th2 Chemokines Secretion In Retro-orbital Cells Of Patients With Graves’ Ophthalmopathy
title_short FRI530 Immune-Modulation By Rapamycin, Or Mycophenolic Acid, Of Th1 And Th2 Chemokines Secretion In Retro-orbital Cells Of Patients With Graves’ Ophthalmopathy
title_sort fri530 immune-modulation by rapamycin, or mycophenolic acid, of th1 and th2 chemokines secretion in retro-orbital cells of patients with graves’ ophthalmopathy
topic Thyroid
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553459/
http://dx.doi.org/10.1210/jendso/bvad114.1875
work_keys_str_mv AT eliagiusy fri530immunemodulationbyrapamycinormycophenolicacidofth1andth2chemokinessecretioninretroorbitalcellsofpatientswithgravesophthalmopathy
AT ragusafrancesca fri530immunemodulationbyrapamycinormycophenolicacidofth1andth2chemokinessecretioninretroorbitalcellsofpatientswithgravesophthalmopathy
AT rosariapaparosabrina fri530immunemodulationbyrapamycinormycophenolicacidofth1andth2chemokinessecretioninretroorbitalcellsofpatientswithgravesophthalmopathy
AT mazzivaleria fri530immunemodulationbyrapamycinormycophenolicacidofth1andth2chemokinessecretioninretroorbitalcellsofpatientswithgravesophthalmopathy
AT patrizioarmando fri530immunemodulationbyrapamycinormycophenolicacidofth1andth2chemokinessecretioninretroorbitalcellsofpatientswithgravesophthalmopathy
AT fallahipoupak fri530immunemodulationbyrapamycinormycophenolicacidofth1andth2chemokinessecretioninretroorbitalcellsofpatientswithgravesophthalmopathy
AT antonellialessandro fri530immunemodulationbyrapamycinormycophenolicacidofth1andth2chemokinessecretioninretroorbitalcellsofpatientswithgravesophthalmopathy
AT martinaferrarisilvia fri530immunemodulationbyrapamycinormycophenolicacidofth1andth2chemokinessecretioninretroorbitalcellsofpatientswithgravesophthalmopathy